Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in BSX — Boston Scientific Corp

CIK 886982 NEW YORK, NY
Back to BSX Full portfolio

Position in BSX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,185,449,403
-$395,350,330 QoQ
Shares Held
18,891,624
+13.9% QoQ
Ownership
1.27%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 84.2607532587726.ToString("F0")% Shared 0.8386521813743679.ToString("F0")% None 14.900594559853038.ToString("F0")%

Common Shares in BSX Over Time

Shares Held

Position Value (USD)

Derivatives in BSX

reported options exposure · as of Mar 31, 2026
CallValue
$29,806,250
CallShares
475,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $6,785,897,738 across 94 Medical Devices names. BSX ranks #2 (17.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 14,505,201 $1,489,248,984
2 BSX
Boston Scientific Corp
This page 		18,891,624 $1,185,449,403
3 SYK
Stryker Corp
 2,669,835 $877,281,079
4 MDT
Medtronic plc
 5,600,590 $485,291,119
5 EW
Edwards Lifesciences Corp
 5,082,050 $406,970,562
6 PEN
Penumbra Inc
 720,575 $236,615,212
7 GEHC
GE HealthCare Technologies Inc.
 3,266,138 $232,483,701
8 DXCM
Dexcom Inc
 3,043,635 $191,140,276

All Filings in BSX

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,185,449,403 18,891,624
2026-03-31 $29,806,250 475,000
2025-12-31 $15,208,325 159,500
2025-12-31 $5,148,900 54,000
2025-12-31 $1,580,799,733 16,578,917
2025-09-30 $41,395,120 424,000
2025-09-30 $15,571,985 159,500
2025-09-30 $1,464,963,432 15,005,259
2025-06-30 $5,800,140 54,000
2025-06-30 $1,496,756,305 13,934,981
2025-06-30 $17,668,945 164,500
2025-03-31 $16,090,360 159,500
2025-03-31 $5,447,520 54,000
2025-03-31 $1,405,241,449 13,929,832
2024-12-31 $1,150,915,707 12,885,308
2024-12-31 $4,823,280 54,000
2024-12-31 $16,032,940 179,500
2024-09-30 $13,366,100 159,500
2024-09-30 $1,109,724,598 13,242,537
2024-09-30 $4,525,200 54,000
2024-06-30 $1,034,152,578 13,428,809
2024-06-30 $9,664,755 125,500
2024-03-31 $1,004,506,389 14,666,468
2024-03-31 $9,588,600 140,000
2024-03-31 $18,101,907 264,300
2023-12-31 $8,839,149 152,900
2023-12-31 $17,649,393 305,300
2023-12-31 $926,491,557 16,026,493
2023-09-30 $877,448,243 16,618,338
2023-09-30 $12,144,000 230,000
2023-09-30 $13,200,000 250,000
2023-06-30 $8,784,216 162,400
2023-06-30 $13,522,500 250,000
2023-06-30 $1,015,335,017 18,771,215
2023-03-31 $894,234,016 17,873,956
2022-12-31 $3,113,971 67,300
2022-12-31 $831,033,672 17,960,529
2022-09-30 $573,204 14,800
2022-09-30 $836,568 21,600
2022-09-30 $753,881,346 19,465,049
2022-06-30 $1,125,554 30,200
2022-06-30 $536,766,636 14,402,110
2022-06-30 $2,549,268 68,400
2022-03-31 $2,373,944 53,600
2022-03-31 $1,922,186 43,400
2022-03-31 $790,374,978 17,845,450
2021-12-31 $4,362,696 102,700
2021-12-31 $1,338,120 31,500
2021-12-31 $805,255,592 18,956,111
2021-09-30 $2,603,400 60,000

Report a Problem

Category
Description
Email (optional, for follow-up)